positive
Recently
Anthem Biosciences rises as Nomura issues positive coverage
Anthem Biosciences rose 4% after Nomura gave a Buy rating, with the stock trading 14% above its IPO price.
Anthem Biosciences gained about 4% after Nomura assigned a Buy rating, noting that the stock trades nearly 14% above its IPO price. The brokerage highlighted a strong pipeline and favourable margin trends. Investor interest increased during the session as broader pharma sentiment improved.